Pricing Log in Create free account

Johnson & Johnson (JNJ) vs Eli Lilly and Company (LLY)

Johnson & Johnson and Eli Lilly and Company are both Drug Manufacturers General companies. Eli Lilly and Company is the larger, with a market value of $1.18T against $610.4B — 1.9× the size. Johnson & Johnson trades at the lower P/E: 29.6× against 42.2×. Eli Lilly and Company grew revenue faster over the last twelve months: 49.6% against 7.80%. Eli Lilly and Company has the higher net margin (33.5% vs 16.2%) and the higher return on invested capital (26.3% vs 0.00%). Both pay a dividend; Johnson & Johnson yields more (2.07% vs 0.53%). Across the 23 metrics below, Eli Lilly and Company leads on 12 and Johnson & Johnson on 11.

Valuation

Metric JNJ LLY Drug Manufacturers General median
P/E 29.61 42.18 24.54
P/S 6.19 14.08 3.39
P/B 7.24 33.11 5.00
Price to free cash flow 27.07 55.01 16.55
EV/EBITDA 18.12 32.68 13.82
EV/Sales 6.36 14.66 4.03
Earnings yield 3.38% 2.37% 2.98%
Free cash flow yield 3.69% 1.82% 4.46%

Profitability

Metric JNJ LLY Drug Manufacturers General median
Gross margin 67.56% 83.40% 72.77%
Operating margin 19.29% 42.22% 18.77%
Net margin 16.20% 33.53% 8.27%
Free cash flow margin 0.00% 22.83% 17.18%
Return on equity 0.00% 102.29% 5.87%
Return on assets 0.00% 21.97% 2.57%
Return on invested capital 0.00% 26.33% 6.11%

Growth

Metric JNJ LLY Drug Manufacturers General median
Revenue growth (TTM) 7.80% 49.58% 6.66%
EPS growth (last fiscal year) 90.50% 95.99% 21.81%
Revenue growth, 5-year CAGR 2.67% 21.58% 4.75%
Net income growth, 5-year CAGR 12.74% 27.22% 0.00%

Health

Metric JNJ LLY Drug Manufacturers General median
Debt to equity 0.44 1.62 0.63
Current ratio 1.09 1.35 1.32
Net debt to EBITDA 0.46 1.19 1.15

Dividend

Metric JNJ LLY Drug Manufacturers General median
Dividend yield 2.07% 0.53% 2.33%
Payout ratio 0.80 0.22 0.59

Size

Metric JNJ LLY Drug Manufacturers General median
Market cap 610.38b 1.18t 123.73b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack